Assessment of pharmacogenetic tests: presenting measures of clinical validity and potential population impact in association studies
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessment of pharmacogenetic tests: presenting measures of clinical validity and potential population impact in association studies
Authors
Keywords
-
Journal
PHARMACOGENOMICS JOURNAL
Volume 17, Issue 4, Pages 386-392
Publisher
Springer Nature
Online
2016-05-11
DOI
10.1038/tpj.2016.34
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
- (2015) Henry M. Dunnenberger et al. Annual Review of Pharmacology and Toxicology
- Clinical Perspective on the Clinical Pharmacogenetics Implementation Consortium Updated 2014 Guidelines for CYP2D6 and Codeine
- (2014) W. T. Nicholson et al. CLINICAL CHEMISTRY
- Meaningful Use of Pharmacogenetics
- (2014) M J Ratain et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update
- (2014) L B Ramsey et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Phenotype Standardization for Statin-Induced Myotoxicity
- (2014) A Alfirevic et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Useless Until Proven Effective: The Clinical Utility of Preemptive Pharmacogenetic Testing
- (2014) A C J W Janssens et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Evidence Required to Demonstrate Clinical Utility of Pharmacogenetic Testing: The Debate Continues
- (2014) N K Gillis et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process
- (2014) Kelly Caudle et al. CURRENT DRUG METABOLISM
- Pharmacogenetic biomarkers for predicting drug response
- (2014) Paul Christiaan Bank et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice
- (2014) Judith A Finegold et al. European Journal of Preventive Cardiology
- SLCO1B1 Genetic Variant Associated With Statin-Induced Myopathy: A Proof-of-Concept Study Using the Clinical Practice Research Datalink
- (2013) D F Carr et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing
- (2013) K E Caudle et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Carbamazepine Dosing
- (2013) S G Leckband et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Predictive ability of direct-to-consumer pharmacogenetic testing: when is lack of evidence really lack of evidence?
- (2013) Rachel RJ Kalf et al. PHARMACOGENOMICS
- The potential impact of pharmacogenetic testing on medication adherence
- (2013) S B Haga et al. PHARMACOGENOMICS JOURNAL
- Current Methodological Issues in the Economic Assessment of Personalized Medicine
- (2013) Lieven Annemans et al. VALUE IN HEALTH
- The Coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system
- (2013) Neda Gharani et al. Genome Medicine
- HLA Genotype and Carbamazepine-Induced Cutaneous Adverse Drug Reactions: A Systematic Review
- (2012) V L Yip et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy
- (2012) R A Wilke et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics: From Bench to Byte— An Update of Guidelines
- (2011) J J Swen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin
- (2011) L R Brunham et al. PHARMACOGENOMICS JOURNAL
- Predictive genetic testing for the identification of high-risk groups: a simulation study on the impact of predictive ability
- (2011) Raluca Mihaescu et al. Genome Medicine
- Economic Opportunities and Challenges for Pharmacogenomics
- (2010) Patricia A. Deverka et al. Annual Review of Pharmacology and Toxicology
- Pharmacogenomics: the importance of accurate phenotypes
- (2010) David Gurwitz et al. PHARMACOGENOMICS
- The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
- (2009) Deepak Voora et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV
- (2008) Bruce R Schackman et al. AIDS
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now